Literature DB >> 19162290

Vaccinia virus exhibits cell-type-dependent entry characteristics.

J Charles Whitbeck1, Chwan-Hong Foo, Manuel Ponce de Leon, Roselyn J Eisenberg, Gary H Cohen.   

Abstract

Differing and sometimes conflicting data have been reported regarding several aspects of vaccinia virus (VV) entry. To address this, we used a beta-galactosidase reporter virus to monitor virus entry into multiple cell types under varying conditions. Entry into HeLa, B78H1 and L cells was strongly inhibited by heparin whereas entry into Vero and BSC-1 cells was unaffected. Bafilomycin also exhibited variable and cell-type-specific effects on VV entry. Entry into B78H1 and BSC-1 cells was strongly inhibited by bafilomycin whereas entry into Vero and HeLa cells was only partially inhibited suggesting the co-existence of both pH-dependent and pH-independent VV entry pathways in these cell types. Finally, entry into HeLa, B78H1, L and BSC-1 cells exhibited a lag of 6-9 min whereas this delay was undetectable in Vero cells. Our results suggest that VV exploits multiple cell attachment and entry pathways allowing it to infect a broad range of cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19162290      PMCID: PMC4041486          DOI: 10.1016/j.virol.2008.12.029

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  42 in total

1.  Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo.

Authors:  C L Lin; C S Chung; H G Heine; W Chang
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  The mode of entry of vaccinia virus into L cells.

Authors:  J A Armstrong; D H Metz; M R Young
Journal:  J Gen Virol       Date:  1973-12       Impact factor: 3.891

3.  An antigenic difference between intracellular and extracellular rabbitpox virus.

Authors:  G Appleyard; A J Hapel; E A Boulter
Journal:  J Gen Virol       Date:  1971-10       Impact factor: 3.891

4.  Further investigations on the mode of entry of vaccinia virus into cells.

Authors:  A Chang; D H Metz
Journal:  J Gen Virol       Date:  1976-08       Impact factor: 3.891

5.  Adsorption and penetration of enveloped and naked vaccinia virus particles.

Authors:  L G Payne; E Norrby
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

6.  Vaccinia virus l1 protein is required for cell entry and membrane fusion.

Authors:  Himani Bisht; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

7.  Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.

Authors:  Patricia L Earl; Jeffrey L Americo; Linda S Wyatt; Leigh Anne Eller; J Charles Whitbeck; Gary H Cohen; Roselyn J Eisenberg; Christopher J Hartmann; David L Jackson; David A Kulesh; Mark J Martinez; David M Miller; Eric M Mucker; Joshua D Shamblin; Susan H Zwiers; John W Huggins; Peter B Jahrling; Bernard Moss
Journal:  Nature       Date:  2004-03-11       Impact factor: 49.962

8.  Poxvirus genomes: a phylogenetic analysis.

Authors:  Caroline Gubser; Stéphane Hué; Paul Kellam; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

Review 9.  Smallpox vaccination and bioterrorism with pox viruses.

Authors:  Anton Mayr
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2003-10       Impact factor: 2.268

10.  Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.

Authors:  Christiana Fogg; Shlomo Lustig; J Charles Whitbeck; Roselyn J Eisenberg; Gary H Cohen; Bernard Moss
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more
  34 in total

1.  Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.

Authors:  Zhenping Wang; Yuping Lai; Jamie J Bernard; Daniel T Macleod; Anna L Cogen; Bernard Moss; Anna Di Nardo
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells.

Authors:  Shu-Jung Chang; Yu-Xun Chang; Roza Izmailyan; Yin-Liang Tang; Wen Chang
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

3.  Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH.

Authors:  Shu-Jung Chang; Ao-Chun Shih; Yin-Liang Tang; Wen Chang
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Vaccinia virus strain differences in cell attachment and entry.

Authors:  Zain Bengali; Alan C Townsley; Bernard Moss
Journal:  Virology       Date:  2009-05-09       Impact factor: 3.616

5.  Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry.

Authors:  Jason Mercer; Stephan Knébel; Florian I Schmidt; Josh Crouse; Christine Burkard; Ari Helenius
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

6.  Vaccinia viral protein A27 is anchored to the viral membrane via a cooperative interaction with viral membrane protein A17.

Authors:  Da-Rong Wang; Jye-Chian Hsiao; Chien-Hsuan Wong; Guo-Chian Li; Su-Ching Lin; Steve S-F Yu; Wenlung Chen; Wen Chang; Der-Lii M Tzou
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

7.  Vaccinia Virus Phospholipase Protein F13 Promotes Rapid Entry of Extracellular Virions into Cells.

Authors:  Peter Bryk; Matthew G Brewer; Brian M Ward
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

8.  A differential role for macropinocytosis in mediating entry of the two forms of vaccinia virus into dendritic cells.

Authors:  Kerrie J Sandgren; John Wilkinson; Monica Miranda-Saksena; Gerald M McInerney; Karen Byth-Wilson; Phillip J Robinson; Anthony L Cunningham
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

9.  A kinome RNAi screen identified AMPK as promoting poxvirus entry through the control of actin dynamics.

Authors:  Theresa S Moser; Russell G Jones; Craig B Thompson; Carolyn B Coyne; Sara Cherry
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

10.  Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells.

Authors:  Kunal P Patel; Carolyn B Coyne; Jeffrey M Bergelson
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.